You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

July 17, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Death due to opioid overdose rising in United States

Drug overdose deaths in the United States increased for the 11th consecutive year in 2010, according to an analysis from the Centers for Disease Control and Prevention (CDC) and continued to rise in 2011, the most recent year for which data were available.
» Full article

MI risk not increased in older men receiving testosterone therapy

Older men treated with intramuscular testosterone did not appear to have an increased risk of myocardial infarction (MI). For men with high MI risk, testosterone use was modestly protective against MI, according to a study. » Full article

Continuing Education

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.


Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Related Articles

FDA defends Zohydro approval in opioid abuse debate

Safety of testosterone products being investigated by FDA

RESOURCES

Latest Clinical News

EDITOR'S PICK

Drugs in Context: Aptiom (eslicarbazepine acetate)

Aptiom (eslicarbazepine acetate) is an oral antiepileptic tablet that was approved by FDA on November 8, 2013, as an add-on medication to treat seizure disorders that can be associated with epilepsy. » Full article

Powered by Modern Medicine Advanstar Medical Communications Group